Document is current

Article History

Received: 2 November 2020

Accepted: 23 August 2021

First Online: 6 September 2021

Declarations

:

: The following research ethics boards approved the study and granted waivers of informed consent: the Interior Health Research Ethics Board (2013-14-052-I); the University of Guelph Research Ethics Board (2018-10-050); the Conjoint Health Research Ethics Board of the University of Calgary (REB19-1025); the Regional Ethics Board Gothenburg (539-11); the Ethics Committee of the Finnish Institute for Health and Welfare (THL/1349/6.02.00/2019); the ACT (Australian Capital Territory) Health Human Research Ethics Committee (2020.LRE.00115); and Comité d’éthique de la recherche du CIUSSS de l’Estrie—CHUS (Centre intégré universitaire de santé et de services sociaux de l'Estrie—Centre hospitalier universitaire de Sherbrooke) (2011-286, 10-181).

: Not applicable.

: MCM reports a scholarship from the Canadian Institutes of Health Research and funding for a Federal Student Work Experience Program placement from the Government of Canada—Genome Research Development Initiative, both related to her PhD program and outside the submitted work. LV reports being a stock holder of Lumed Inc., outside the submitted work. All other authors declare that they have no competing interests.